• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,616.40 47.01
( 0.06%)
Global Indices
Nasdaq
52,658.24 149.83
(0.29%)
Dow Jones
7,594.79 30.15
(0.40%)
Hang Seng
67,217.35 -1,340.38
(-1.96%)
Nikkei 225
10,494.06 -3.23
(-0.03%)
Forex
USD-INR
95.45 -0.01
(-0.01%)
EUR-INR
109.10 0.17
(0.15%)
GBP-INR
127.94 0.35
(0.28%)
JPY-INR
0.59 0.00
(0.03%)

EQUITY - MARKET SCREENER

Hemo Organic Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
524590
INE422G01015
-2.6951153
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
8.06
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

vikas globalone ltd
Fredun Pharmaceuticals standalone net profit rises 56.58% in the March 2026 quarter
May 25,2026
Net profit of Fredun Pharmaceuticals rose 56.58% to Rs 11.07 crore in the quarter ended March 2026 as against Rs 7.07 crore during the previous quarter ended March 2025. Sales rose 27.18% to Rs 210.41 crore in the quarter ended March 2026 as against Rs 165.44 crore during the previous quarter ended March 2025.

For the full year,net profit rose 59.59% to Rs 33.21 crore in the year ended March 2026 as against Rs 20.81 crore during the previous year ended March 2025. Sales rose 40.21% to Rs 633.33 crore in the year ended March 2026 as against Rs 451.71 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales210.41165.44 27 633.33451.71 40
OPM %13.8510.54 -14.9712.20 -
PBDT14.659.29 58 55.5032.72 70
PBT11.548.04 44 47.5928.27 68
NP11.077.07 57 33.2120.81 60